Craig Lipset is Appointed Chairman of the Trialbee Industry Advisory Board
Trialbee, the leading global data and technology platform provider for patient matching and enrollment in clinical trials, today announced the appointment of Craig Lipset as Chairman of the Trialbee Industry Advisory Board. Craig is a recognized visionary leader who has spent his career dedicated to transforming some of the most challenging issues in clinical research through new innovations.
Craig is the former Head of Clinical Innovation and Venture Partner at Pfizer and a distinguished leader at the forefront of innovation in clinical research and medicine development. Most recently Craig cofounded and co-Chairs the Decentralized Trials Research Alliance (DTRA), which roughly 100 leading life science organizations have joined the first few months since it was established. The core mission of DTRA is making clinical trial participation widely accessible by advancing policies, research practices and new te
Mon Feb 22 2021 | Paul Ohanian | Fuel
Last week, US Lacrosse hosted its latest ‘
Return to Play’ webinar, with health and medical experts providing guidance to help the lacrosse community navigate a safe return to the field for the spring season.
Serving as panelists for the session were Dr. Karen Sutton from the Hospital for Special Surgery and head team physician for the U.S. Women’s National Team; Dr. Andrew Lincoln, director of the MedStar Health Research Institute; Nina Walker, head athletic trainer for the men’s lacrosse team at the University of North Carolina; and Ann Kit Carpenetti, vice president of lacrosse operations at US Lacrosse.
Johns Hopkins Seeks Paid Volunteers for Another Potential Covid Treatment
The university needs people who recently tested positive or were recently exposed to the coronavirus. Share
John Hopkins University is seeking paid volunteers to help with two studies evaluating the efficacy of Covid-19 antibodies as a potential treatment for the virus. The university needs people who recently tested positive for the coronavirus, or who were recently exposed to it. It’s assessing whether antibodies from Covid survivors can prevent people who were exposed from getting seriously ill. The clinical trial locations are at MedStar Georgetown University Hospital, Medstar Health Research Institute, Anne Arundel Research Institute, and Johns Hopkins University.
The newest curse of covid-19 is vaccine envy
Petula Dvorak, The Washington Post
Feb. 4, 2021
FacebookTwitterEmail
We have now reached the envy stage of the pandemic.
Social media posts like: I got a golden ticket to get the vaccine!!! First vaccinedose done! or photos of (some really cool) buttons, stickers, pins and medical cards declaring the bearer vaccinated are being met with resentment: How did you get it so early? Lowkey jealous.
Or, Highkey jealous.
And a pointed, Are you part of a risk group? Hawaii only vaccinating people over 75 right now.
That s what D.C. therapist Yuly Rios got from an Aloha State friend who wondered when she d get a shot at the vaccine. (Who lives in Hawaii and is jealous of anything in D.C.? Woman, please.)
Fri Jan 8 2021 | Paul Ohanian | High School
PHOTO BY JOHN STROHSACKER
Findings from a new research study measuring the effects of headgear in high school girls lacrosse indicate that headgear is associated with a reduction in the magnitude of overall impacts but not a change in the rate of impacts, how they occur, or how penalties were administered for impacts sustained during competition.
The findings were recently published in an
The research team included two members of US Lacrosse Sports Science & Safety Committee, Dr. Shane Caswell of George Mason University, and Dr. Andrew Lincoln of MedStar Health Research Institute. The researchers monitored 49 high school players over the course of two seasons; one season with no headgear used and the second with headgear that meets ASTM standard F3137.